node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
DEFB103A | DEFB104A | ENSP00000320951 | ENSP00000320813 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.473 |
DEFB103A | DEFB105A | ENSP00000320951 | ENSP00000334330 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 105A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB105B | ENSP00000320951 | ENSP00000335281 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 105B; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB106B | ENSP00000320951 | ENSP00000334364 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 106B | 0.473 |
DEFB103A | DEFB107A | ENSP00000320951 | ENSP00000334681 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 107A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB107B | ENSP00000320951 | ENSP00000347810 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 107B; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB108B | ENSP00000320951 | ENSP00000333234 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 108B; Has antibacterial activity (By similarity) | 0.473 |
DEFB104A | DEFB103A | ENSP00000320813 | ENSP00000320951 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.473 |
DEFB104A | DEFB105A | ENSP00000320813 | ENSP00000334330 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 105A; Has antibacterial activity (Potential) | 0.728 |
DEFB104A | DEFB106B | ENSP00000320813 | ENSP00000334364 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 106B | 0.473 |
DEFB104A | DEFB107A | ENSP00000320813 | ENSP00000334681 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 107A; Has antibacterial activity (Potential) | 0.681 |
DEFB104A | DEFB108B | ENSP00000320813 | ENSP00000333234 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 108B; Has antibacterial activity (By similarity) | 0.564 |
DEFB105A | DEFB103A | ENSP00000334330 | ENSP00000320951 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.473 |
DEFB105A | DEFB104A | ENSP00000334330 | ENSP00000320813 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.728 |
DEFB105A | DEFB106B | ENSP00000334330 | ENSP00000334364 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 106B | 0.473 |
DEFB105A | DEFB107A | ENSP00000334330 | ENSP00000334681 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 107A; Has antibacterial activity (Potential) | 0.473 |
DEFB105A | DEFB107B | ENSP00000334330 | ENSP00000347810 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 107B; Has antibacterial activity (Potential) | 0.473 |
DEFB105A | DEFB108B | ENSP00000334330 | ENSP00000333234 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 108B; Has antibacterial activity (By similarity) | 0.666 |
DEFB105B | DEFB103A | ENSP00000335281 | ENSP00000320951 | defensin, beta 105B; Has antibacterial activity (Potential) | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.473 |
DEFB105B | DEFB106B | ENSP00000335281 | ENSP00000334364 | defensin, beta 105B; Has antibacterial activity (Potential) | defensin, beta 106B | 0.473 |